These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 8492642)
1. Comparison of antitumor activity of vitamins K1, K2 and K3 on human tumor cells by two (MTT and SRB) cell viability assays. Wu FY; Liao WC; Chang HM Life Sci; 1993; 52(22):1797-804. PubMed ID: 8492642 [TBL] [Abstract][Full Text] [Related]
2. Cytotoxic effect through fas/APO-1 expression due to vitamin K in human glioma cells. Sun LK; Yoshii Y; Miyagi K J Neurooncol; 2000 Mar; 47(1):31-8. PubMed ID: 10930097 [TBL] [Abstract][Full Text] [Related]
3. Comparison of in vitro anticancer-drug-screening data generated with a tetrazolium assay versus a protein assay against a diverse panel of human tumor cell lines. Rubinstein LV; Shoemaker RH; Paull KD; Simon RM; Tosini S; Skehan P; Scudiero DA; Monks A; Boyd MR J Natl Cancer Inst; 1990 Jul; 82(13):1113-8. PubMed ID: 2359137 [TBL] [Abstract][Full Text] [Related]
4. Antitumor effects of vitamins K1, K2 and K3 on hepatocellular carcinoma in vitro and in vivo. Hitomi M; Yokoyama F; Kita Y; Nonomura T; Masaki T; Yoshiji H; Inoue H; Kinekawa F; Kurokohchi K; Uchida N; Watanabe S; Kuriyama S Int J Oncol; 2005 Mar; 26(3):713-20. PubMed ID: 15703828 [TBL] [Abstract][Full Text] [Related]
5. Assay of anticancer drugs in tissue culture: comparison of a tetrazolium-based assay and a protein binding dye assay in short-term cultures derived from human malignant glioma. Haselsberger K; Peterson DC; Thomas DG; Darling JL Anticancer Drugs; 1996 May; 7(3):331-8. PubMed ID: 8792008 [TBL] [Abstract][Full Text] [Related]
6. Binary/ternary combined effects of vitamin K3 with other antitumor agents in nasopharyngeal carcinoma CG1 cells. Liao WC; Wu FY; Wu CW Int J Oncol; 2000 Aug; 17(2):323-8. PubMed ID: 10891542 [TBL] [Abstract][Full Text] [Related]
7. Novel role of vitamin K2: a potent inducer of differentiation of various human myeloid leukemia cell lines. Sakai I; Hashimoto S; Yoda M; Hida T; Ohsawa S; Nakajo S; Nakaya K Biochem Biophys Res Commun; 1994 Dec; 205(2):1305-10. PubMed ID: 7802663 [TBL] [Abstract][Full Text] [Related]
8. Naturally occurring K vitamins inhibit pancreatic cancer cell survival through a caspase-dependent pathway. Showalter SL; Wang Z; Costantino CL; Witkiewicz AK; Yeo CJ; Brody JR; Carr BI J Gastroenterol Hepatol; 2010 Apr; 25(4):738-44. PubMed ID: 19929921 [TBL] [Abstract][Full Text] [Related]
9. Comparison of the sulforhodamine B protein and tetrazolium (MTT) assays for in vitro chemosensitivity testing. Keepers YP; Pizao PE; Peters GJ; van Ark-Otte J; Winograd B; Pinedo HM Eur J Cancer; 1991; 27(7):897-900. PubMed ID: 1834124 [TBL] [Abstract][Full Text] [Related]
10. Scanning electron microscopy and transmission electron microscopy aspects of synergistic antitumor activity of vitamin C - vitamin K3 combinations against human prostatic carcinoma cells. Gilloteaux J; Jamison JM; Venugopal M; Giammar D; Summers JL Scanning Microsc; 1995 Mar; 9(1):159-73. PubMed ID: 8553014 [TBL] [Abstract][Full Text] [Related]
11. Vitamins K2, K3 and K5 exert in vivo antitumor effects on hepatocellular carcinoma by regulating the expression of G1 phase-related cell cycle molecules. Kuriyama S; Hitomi M; Yoshiji H; Nonomura T; Tsujimoto T; Mitoro A; Akahane T; Ogawa M; Nakai S; Deguchi A; Masaki T; Uchida N Int J Oncol; 2005 Aug; 27(2):505-11. PubMed ID: 16010434 [TBL] [Abstract][Full Text] [Related]
12. A comparison of clonogenic, microtetrazolium and sulforhodamine B assays for determination of cisplatin cytotoxicity in human ovarian carcinoma cell lines. Perez RP; Godwin AK; Handel LM; Hamilton TC Eur J Cancer; 1993; 29A(3):395-9. PubMed ID: 8398340 [TBL] [Abstract][Full Text] [Related]
13. DNA polymerase gamma inhibition by vitamin K3 induces mitochondria-mediated cytotoxicity in human cancer cells. Sasaki R; Suzuki Y; Yonezawa Y; Ota Y; Okamoto Y; Demizu Y; Huang P; Yoshida H; Sugimura K; Mizushina Y Cancer Sci; 2008 May; 99(5):1040-8. PubMed ID: 18312466 [TBL] [Abstract][Full Text] [Related]
14. Evaluation of a rapid tetrazolium-based colorimetric assay for selecting anticancer drugs. Chen CF; Hwang JM; Wu CH; Chen CS; Chen KY Zhonghua Yi Xue Za Zhi (Taipei); 1990 Jul; 46(1):7-16. PubMed ID: 2176928 [TBL] [Abstract][Full Text] [Related]
15. Vitamin K3 analogs induce selective tumor cytotoxicity in neuroblastoma. Kitano T; Yoda H; Tabata K; Miura M; Toriyama M; Motohashi S; Suzuki T Biol Pharm Bull; 2012; 35(4):617-23. PubMed ID: 22466570 [TBL] [Abstract][Full Text] [Related]
16. Synergistic antitumor activity of vitamins C and K3 on human urologic tumor cell lines. Venugopal M; Jamison JM; Gilloteaux J; Koch JA; Summers M; Giammar D; Sowick C; Summers JL Life Sci; 1996; 59(17):1389-400. PubMed ID: 8890917 [TBL] [Abstract][Full Text] [Related]
17. Vitamins K2, K3 and K5 exert antitumor effects on established colorectal cancer in mice by inducing apoptotic death of tumor cells. Ogawa M; Nakai S; Deguchi A; Nonomura T; Masaki T; Uchida N; Yoshiji H; Kuriyama S Int J Oncol; 2007 Aug; 31(2):323-31. PubMed ID: 17611688 [TBL] [Abstract][Full Text] [Related]
18. Comparison of two colorimetric assays as cytotoxicity endpoints for an in vitro screen for antitumour agents. Fricker SP; Buckley RG Anticancer Res; 1996; 16(6B):3755-60. PubMed ID: 9042253 [TBL] [Abstract][Full Text] [Related]
19. Alternative therapeutic approach to renal-cell carcinoma: induction of apoptosis with combination of vitamin K3 and D-fraction. Degen M; Alexander B; Choudhury M; Eshghi M; Konno S J Endourol; 2013 Dec; 27(12):1499-503. PubMed ID: 24341344 [TBL] [Abstract][Full Text] [Related]
20. Oral supplementation of vitamin K for pregnant women and effects on levels of plasma vitamin K and PIVKA-II in the neonate. Motohara K; Takagi S; Endo F; Kiyota Y; Matsuda I J Pediatr Gastroenterol Nutr; 1990 Jul; 11(1):32-6. PubMed ID: 2388129 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]